Home/Filings/4/0001299130-21-000107
4//SEC Filing

Hunkapiller Michael 4

Accession 0001299130-21-000107

CIK 0001299130other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 8:31 PM ET

Size

22.5 KB

Accession

0001299130-21-000107

Insider Transaction Report

Form 4
Period: 2021-02-26
Transactions
  • Sale

    Common Stock

    2021-02-26$31.49/sh43,946$1,383,991867,881 total
  • Sale

    Common Stock

    2021-02-26$32.74/sh15,771$516,311852,110 total
  • Sale

    Common Stock

    2021-02-26$30.69/sh170,824$5,242,076911,827 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-02-2645,1340 total
    Exercise: $5.27Exp: 2027-02-15Common Stock (45,134 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-02-2679,3630 total
    Exercise: $7.87Exp: 2026-03-15Common Stock (79,363 underlying)
  • Exercise/Conversion

    Common Stock

    2021-02-26$7.87/sh+79,363$624,5871,037,517 total
  • Exercise/Conversion

    Common Stock

    2021-02-26$5.27/sh+45,134$237,8561,082,651 total
  • Sale

    Common Stock

    2021-02-26$33.33/sh3,705$123,488848,405 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-02-26109,7490 total
    Exercise: $5.72Exp: 2025-03-16Common Stock (109,749 underlying)
  • Exercise/Conversion

    Common Stock

    2021-02-26$5.72/sh+109,749$627,764958,154 total
Footnotes (6)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2020.
  • [F2]This sale price represents the weighted average sale price of the shares sold ranging from $30.20 to $31.19 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  • [F3]This sale price represents the weighted average sale price of the shares sold ranging from $31.20 to $32.18 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  • [F4]This sale price represents the weighted average sale price of the shares sold ranging from $32.23 to $33.20 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  • [F5]This sale price represents the weighted average sale price of the shares sold ranging from $33.23 to $33.43 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  • [F6]The shares subject to the option are fully vested and exercisable.

Issuer

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

CIK 0001299130

Entity typeother

Related Parties

1
  • filerCIK 0001317102

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 8:31 PM ET
Size
22.5 KB